The Global Fund is an international financing mechanism charged with mobilisation and disbursement of additional resources to countries to address high disease burden among populations afflicted by HIV/AIDS, Tuberculosis and Malaria. Between 2003 and 2014, the Global Fund has signed 16 grants with Kenya worth USD 896 million, out of which USD 697 million has been disbursed. Kenya is running the 7th largest Global Fund portfolio globally. This puts the country in a critical position to demonstrate results in bringing more patients to treatment, alleviating suffering, ensuring accountability, engaging in meaningful partnerships and strengthening the health and community systems.
Kenya successfully applied for funding support from GF to support HIV, TB and Malaria under the New Funding Model (NFM). This funding is running for two years starting this fiscal year 2015/16. Kenya today signed Tuberculosis grants amounting to KShs 6.6 billion for the fiscal year 2015/2016 and 2016/17. The funds will be managed by two principal recipients namely The National Treasury, KShs 4.3 billion and Amref Health Africa, KShs 2.3 billion. These funds are to support 1. Enrolment of 3,000 Multi-Drug Resistant TB patients into care and support 2. National rollout of isoniazid preventive therapy (IPT) for PLHIVs, prisoners and other key populations, 3. Provision of therapeutic and supplementary feeds for TB patients and 4. Roll out of TB molecular testing using GeneXpert